BAX
Price
$33.82
Change
+$0.38 (+1.14%)
Updated
Feb 21 closing price
Capitalization
21.77B
60 days until earnings call
NHNKY
Price
$15.34
Change
-$0.28 (-1.79%)
Updated
Feb 21 closing price
Capitalization
2.23B
Ad is loading...

BAX vs NHNKY

Header iconBAX vs NHNKY Comparison
Open Charts BAX vs NHNKYBanner chart's image
Baxter International
Price$33.82
Change+$0.38 (+1.14%)
Volume$7.26M
Capitalization21.77B
Nihon Kohden
Price$15.34
Change-$0.28 (-1.79%)
Volume$2.25K
Capitalization2.23B
BAX vs NHNKY Comparison Chart
Loading...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NHNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAX vs. NHNKY commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a Hold and NHNKY is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (BAX: $33.82 vs. NHNKY: $15.34)
Brand notoriety: BAX and NHNKY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BAX: 147% vs. NHNKY: 51%
Market capitalization -- BAX: $21.77B vs. NHNKY: $2.23B
BAX [@Medical Specialties] is valued at $21.77B. NHNKY’s [@Medical Specialties] market capitalization is $2.23B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAX’s FA Score shows that 2 FA rating(s) are green whileNHNKY’s FA Score has 2 green FA rating(s).

  • BAX’s FA Score: 2 green, 3 red.
  • NHNKY’s FA Score: 2 green, 3 red.
According to our system of comparison, NHNKY is a better buy in the long-term than BAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAX’s TA Score shows that 6 TA indicator(s) are bullish while NHNKY’s TA Score has 6 bullish TA indicator(s).

  • BAX’s TA Score: 6 bullish, 4 bearish.
  • NHNKY’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, NHNKY is a better buy in the short-term than BAX.

Price Growth

BAX (@Medical Specialties) experienced а +9.73% price change this week, while NHNKY (@Medical Specialties) price change was -3.03% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.75%. For the same industry, the average monthly price growth was -1.45%, and the average quarterly price growth was +2.31%.

Reported Earning Dates

BAX is expected to report earnings on Apr 24, 2025.

Industries' Descriptions

@Medical Specialties (-1.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAX($21.8B) has a higher market cap than NHNKY($2.23B). BAX has higher P/E ratio than NHNKY: BAX (85.61) vs NHNKY (18.12). BAX YTD gains are higher at: 15.981 vs. NHNKY (6.899). NHNKY has higher annual earnings (EBITDA): 27.2B vs. BAX (1.67B). NHNKY has more cash in the bank: 43.7B vs. BAX (3.19B). NHNKY has less debt than BAX: NHNKY (433M) vs BAX (14.4B). NHNKY has higher revenues than BAX: NHNKY (202B) vs BAX (14.8B).
BAXNHNKYBAX / NHNKY
Capitalization21.8B2.23B976%
EBITDA1.67B27.2B6%
Gain YTD15.9816.899232%
P/E Ratio85.6118.12473%
Revenue14.8B202B7%
Total Cash3.19B43.7B7%
Total Debt14.4B433M3,326%
FUNDAMENTALS RATINGS
BAX vs NHNKY: Fundamental Ratings
BAX
NHNKY
OUTLOOK RATING
1..100
3450
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
12
Undervalued
PROFIT vs RISK RATING
1..100
10073
SMR RATING
1..100
8816
PRICE GROWTH RATING
1..100
5544
P/E GROWTH RATING
1..100
1338
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAX's Valuation (6) in the Medical Specialties industry is in the same range as NHNKY (12) in the null industry. This means that BAX’s stock grew similarly to NHNKY’s over the last 12 months.

NHNKY's Profit vs Risk Rating (73) in the null industry is in the same range as BAX (100) in the Medical Specialties industry. This means that NHNKY’s stock grew similarly to BAX’s over the last 12 months.

NHNKY's SMR Rating (16) in the null industry is significantly better than the same rating for BAX (88) in the Medical Specialties industry. This means that NHNKY’s stock grew significantly faster than BAX’s over the last 12 months.

NHNKY's Price Growth Rating (44) in the null industry is in the same range as BAX (55) in the Medical Specialties industry. This means that NHNKY’s stock grew similarly to BAX’s over the last 12 months.

BAX's P/E Growth Rating (13) in the Medical Specialties industry is in the same range as NHNKY (38) in the null industry. This means that BAX’s stock grew similarly to NHNKY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAXNHNKY
RSI
ODDS (%)
Bearish Trend 3 days ago
44%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
68%
Momentum
ODDS (%)
Bullish Trend 3 days ago
55%
Bearish Trend 3 days ago
61%
MACD
ODDS (%)
Bullish Trend 3 days ago
43%
Bullish Trend 3 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
53%
Bearish Trend 3 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
54%
Bullish Trend 3 days ago
65%
Advances
ODDS (%)
Bullish Trend 3 days ago
49%
Bullish Trend 10 days ago
58%
Declines
ODDS (%)
Bearish Trend 12 days ago
58%
Bearish Trend 3 days ago
62%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
59%
Bullish Trend 6 days ago
59%
Aroon
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
67%
View a ticker or compare two or three
Ad is loading...
BAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NHNKY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FCBC40.22-0.50
-1.23%
First Community Bankshares
OFS8.25-0.12
-1.43%
OFS Capital Corp
FULT19.68-0.45
-2.24%
Fulton Financial Corp
DINO36.30-1.13
-3.02%
HF Sinclair Corp
ESGL0.98-0.13
-11.90%
ESGL Holdings Limited

BAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAX has been loosely correlated with TFX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BAX jumps, then TFX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAX
1D Price
Change %
BAX100%
+1.14%
TFX - BAX
39%
Loosely correlated
+0.29%
DGX - BAX
36%
Loosely correlated
+0.06%
ICUI - BAX
35%
Loosely correlated
-3.61%
SYK - BAX
34%
Loosely correlated
-0.94%
ABT - BAX
34%
Loosely correlated
+1.31%
More

NHNKY and

Correlation & Price change

A.I.dvisor tells us that NHNKY and CNMD have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NHNKY and CNMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NHNKY
1D Price
Change %
NHNKY100%
-1.82%
CNMD - NHNKY
29%
Poorly correlated
-0.29%
ODYY - NHNKY
28%
Poorly correlated
-3.23%
NGMDF - NHNKY
27%
Poorly correlated
N/A
BAX - NHNKY
26%
Poorly correlated
+1.14%
PSNL - NHNKY
25%
Poorly correlated
-13.17%
More